NASDAQ:ATNX - Athenex, Inc.
$11.06
 $-0.20
-1.78%
4:00PM EDT
2019-04-18
Athenex, Inc. is an oncology pharmaceutical company focused on the development and commercialization of therapies for cancer diseases and supportive therapies. The Company's technology platform is organized into three categories, including Oral Absorption Platform, Src Kinase Inhibitors and Symptom Therapeutics. The Company's business includes medical technology centers and a manufacturing supply chain across both China and North America. The Company has approximately 10 products under development throughout the world with multiple offices in China and the United States.The Company's delivery system (P-glycoprotein (P-gp) pump inhibitor), is a technology platform, which enables oral absorption of a range of anticancer drugs and are given intravenously due to poor oral absorption. It offers Oraxol, an oral formulation of paclitaxel used for the treatment of breast, lung, ovarian and pancreatic cancer. It also offers Orateacan, an oral formulation of Irinotecan, which is delivered intravenously to treat colorectal cancer. The Company's Oradoxel is an oral formulation of Docetaxel, which is used to treat head and neck, gastric, breast, prostate and non-small cell lung cancers. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ATNX     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 79   199. 07   233. 87  
42 stocks rank:  3. 55 K 1. 43 K 1. 06 K
# analyst opinions:  7. 00   14. 48   14. 09  
mean recommendation:  1. 90   2. 09   2. 01  

quick ratio:  2. 33   5. 29   1. 92  
current ratio:  3. 31   5. 64   2. 40  

target price low:  12. 10   84. 50   115. 74  
target price avg:  15. 50   110. 73   137. 39  
target price high:  26. 37   136. 41   157. 80  
1-yr high:  19. 97   114. 11   138. 85  
last close:  11. 06   87. 56   116. 78  
50-day avg:  12. 21   95. 43   123. 53  
200-day avg:  13. 99   94. 13   121. 20  
1-yr low:  10. 24   72. 67   98. 41  
volume:  325. 14 K 2. 43 M 4. 85 M
50-day avg volume:  272. 24 K 2. 72 M 4. 97 M
200-day avg volume:  298. 44 K 2. 90 M 4. 58 M

1-day return:  -1. 78 % -0. 40 % 0. 07 %
this week return:  -6. 90 % -5. 72 % -4. 11 %
12-wk return:  -7. 91 % 1. 78 % -0. 04 %
52-wk return:  -30. 01 % 10. 81 % 14. 09 %

enterprise value (EV):  724. 99 M 51. 19 B 117. 96 B
market cap:  741. 32 M 43. 00 B 104. 52 B
EBITDA:  -123. 25 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -5. 88   4. 34   13. 27  
enterprise/revenue (EV/R):  8. 14   68. 16   13. 68  
total revenue:  89. 10 M 10. 61 B 38. 24 B
total debt:  46. 76 M 12. 22 B 16. 66 B
debt/equity:  36. 32   46. 86   89. 46  
net income (common):  -117. 44 M 2. 20 B 4. 21 B

shares outstanding:  67. 02 M 570. 91 M 1. 24 B
shares:  40. 52 M 571. 02 M 1. 23 B
shares short:  5. 16 M 9. 93 M 16. 79 M
shares short prior month:  5. 60 M 9. 96 M 16. 58 M
short ratio:  17. 24   5. 31   3. 30  
short % of float:  14. 69 % 5. 81 % 2. 61 %
total cash/share:  1. 60   11. 13   9. 30  
total cash:  107. 42 M 6. 70 B 7. 10 B
free cash flow:  -92. 43 M 3. 58 B 4. 74 B
operating cash flow:  -109. 39 M 4. 14 B 6. 32 B

book value:  2. 08   12. 76   26. 84  
price/book:  5. 32   3. 08   -1. 74  
operating margins:  -142. 00 % -721. 97 % -88. 82 %
EBITDA margins:  -138. 33 % 10. 94 % 22. 54 %
profit margins:  -131. 81 % 7. 81 % 10. 60 %
gross margins:  -86. 99 % 37. 02 % 55. 68 %

1-yr max volatility:  15. 68 % --- ---
1-yr mean volatility:  -0. 13 % 0. 03 % 0. 04 %

1-yr EPS:  -1. 82   2. 39   4. 08  
forward EPS:  -1. 30   3. 97   7. 14  
P/E:  -6. 08   13. 59   22. 83  
forward P/E:  -9. 14   -20. 05   14. 49  
PE/G:  -0. 14   -1. 46   1. 68  
growth:  43. 00 % 126. 81 % 29. 29 %
earnings high:  -0. 40   1. 02   1. 63  
earnings avg:  -0. 46   0. 76   1. 51  
earnings low:  -0. 51   0. 47   1. 39  
revenue high:  20. 10 M 2. 68 B 10. 71 B
revenue avg:  17. 68 M 2. 59 B 10. 49 B
revenue low:  16. 16 M 2. 49 B 10. 25 B
return on assets:  -42. 57 % -2. 80 % 5. 29 %
return on equity:  -117. 28 % -18. 52 % 7. 38 %
revenue growth:  43. 00 % 92. 55 % 19. 15 %
revenue/share:  1. 38   13. 27   55. 24  

beta (1yr vs S&P500):  1. 51   1. 24   0. 93  
sharpe (1yr):  -0. 66   0. 29   0. 60  

held % insiders:  31. 44 % 6. 38 % 3. 38 %
held % institutions:  32. 25 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : ATNX
.    + 1.508 =         1.508 :: INITIAL WEIGHT
.   + 31.888 =        33.396 :: inverse volume-to-price addition
.   + 43.809 =        77.205 :: spline projection addition
.    x 1.824 =       140.802 :: 13 weeks' performance factor
.    x 0.777 =       109.414 :: one-year gains+dividend factor
.    x 1.432 =       156.684 :: industry recommendation factor
.    x 2.331 =       365.299 :: symbol recommendation factor
.    x 1.119 =       408.906 :: EV/R factor
.    x 0.996 =       407.166 :: return on assets factor
.    x 0.988 =        402.39 :: return on equity factor
.    x 2.423 =       974.803 :: revenue growth factor
.    x 2.586 =       2521.16 :: current ratio factor
.    x 1.324 =      3337.511 :: quick ratio factor
.    x 1.029 =      3432.942 :: short ratio factor
.    x 2.079 =      7135.593 :: price-to-book factor
.    x 1.332 =      9506.607 :: debt-to-equity factor
.    x 2.066 =     19636.116 :: P/E weight
.    x 1.631 =      32017.13 :: PE/G factor
.    x 1.535 =      49136.66 :: beta factor
.    x 0.663 =     32580.627 :: sharpe factor
.    x 1.309 =     42632.993 :: target low factor
.    x 1.211 =     51637.055 :: target mean factor
.    x 1.118 =     57712.408 :: target high factor
.    x 1.312 =     75698.387 :: industry 2-weeks return factor
.     x 0.95 =     71878.584 :: "drift" penalty 2 days ago
.    x 0.943 =     67783.367 :: "drift" penalty 4 days ago
.    x 0.997 =      67552.72 :: overall "drift" factor
.    x 0.843 =     56963.056 :: largest single-day jump factor
.    x 0.163 =      9307.689 :: low price factor
.      x 1.0 =      9306.188 :: factor hist industry gain for week 15
.   cubeRoot =        21.034 :: reduced to standardize
.   - 20.246 =         0.788 :: add/subtract for performance
.                      0.788 :: FINAL WEIGHT for NASDAQ:ATNX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org